SCI & TECH● LOWSep 1 · Sep 1, 2026, 6:33 AM
GSK to advance mRNA seasonal flu vaccine to phase 3 trial
Seeking Alpha Tech · global
GSK is progressing its mRNA seasonal flu vaccine to a phase 3 clinical trial. This move marks a significant step in the development of new vaccine technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH31m agoWorld Bank To Boost Digital Connectivity In Developing CountriesChannels TVSCI & TECH52m agoDistinguished clinician - scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine , united states japanherald.com · JapanSCI & TECH1h agoSpace probe en route to Mars moon to retrieve 10 grams of materialNOS BuitenlandSCI & TECH1h agoAI boom drives shift toward engineering in Israeli universitiesjns.org · Israel